B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]
Ausschreibungsinformationen
TED EULisboa, Portugal
- Art
- 29
- Verfahren
- restricted
- Referenznummer
- 359903-2026
- Geschätzter Wert
- 1,410,777 EUR
- CPV
- 33600000
AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO]